Reneo Pharmaceuticals Inc is a clinical stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing ... Reneo Pharmaceuticals Inc is a clinical stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing REN001 to modulate genes critical to metabolism and generation of ATP, which is the primary source of energy for cellular processes. 더 보기
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.35 | -6.08695652174 | 5.75 | 6.18 | 5 | 142168 | 5.69694427 | CS |
4 | -2.49 | -31.5589353612 | 7.89 | 9.4017 | 5 | 136646 | 7.0923368 | CS |
12 | -10.97 | -67.0128283445 | 16.37 | 17.74 | 5 | 115256 | 9.99620534 | CS |
26 | -13.05 | -70.7317073171 | 18.45 | 19.8499 | 5 | 103361 | 11.52843004 | CS |
52 | -13.05 | -70.7317073171 | 18.45 | 19.8499 | 5 | 103361 | 11.52843004 | CS |
156 | -13.05 | -70.7317073171 | 18.45 | 19.8499 | 5 | 103361 | 11.52843004 | CS |
260 | -13.05 | -70.7317073171 | 18.45 | 19.8499 | 5 | 103361 | 11.52843004 | CS |
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관